doi: 10.3967/bes2018.090
The Bidirectional Effects of Arsenic on miRNA-21: A Systematic Review and Meta-analysis
-
Abstract:
Objective Arsenic is a metalloid environmental carcinogen involved in the occurrence and development of many cancers. miRNA-21 plays a crucial role in arsenic-induced carcinogenesis. We aimed to elucidate the mechanism by which miRNA-21 influences arsenic-induced cancer. Methods We used meta-analysis of published studies to determine how arsenic induces cancerous cells through miRNA-21. Results Low-dose arsenic exposure (≤ 5 μmol/L) can increase miRNA-21 and phosphorylated signal transducter and activator of transcription 3 (pSTAT3) expression, and decrease programmed cell death protein 4 (PDCD4) and protein sprouty homolog 1 (Spry1) expression. High-dose arsenic exposure (> 5 μmol/L), can increase miRNA-21 expression, and decrease Spry1 and E-cadherin expression. Short-term arsenic exposure (≤ 24 h) can increase miRNA-21 and pSTAT3 expression, and decrease PDCD4 expression. Moreover, long-term arsenic exposure (> 24 h) can increase the miRNA-21, STAT3, and pSTAT3 expression, and decrease PDCD4 expression. We found that activation of miRNA-21 and pSTAT3 were most pronounced following long-term arsenic exposure at low doses, and the effects on PDCD4 expression were most pronounced following short-term arsenic exposure at low doses. miRNA-21 inhibitors increased the expression of tumor suppressor genes PDCD4, PTEN, and Spry1 and miRNA-21-mimics suppressed the expression of these tumor suppressor genes. Conclusion Arsenic can cause cancer by activating miRNA-21 and inhibiting the expression of PDCD4, PTEN, and Spry1. -
Figure 3. Effect of arsenic on malignant cell proliferation. SMD, standardized mean difference; E-cadherin, a type of cell adhesion molecule; N-cadherin, a type of cell adhesion molecule; Vimentin, a type Ⅲ intermediate filament (IF) protein. Arsenic can inhibit the expression of E-cadherin and N-cadherin, promote the expression of Vimentin, and cause malignant proliferation of cells.
Figure 6. The Effect of ARSENIC on miRNA-21. Forest plot shows the effect of arsenic treatment on miRNA-21 expression in treatment and control groups. SMD, standardized mean difference; Ⅳ, independent variable; 95% CI, 95% confidence interval; SD, standard deviation. Arsenic can promote the expression of miRNA-21.
Figure 8. The effects of arsenic on PDCD4, PTEN, and Spry1. SMD, standardized mean difference; PDCD4, programmed cell death protein 4; PTEN, phosphatase and tensin homolog; Spry1, protein sprouty homolog 1; anti-miRNA-21, miRNA-21 inhibitor; miRNA-21 mimic, miRNA-21 agonist. Compared with arsenic group, anti-miRNA-21 could promote the expression of PDCD4, PTEN, and Spry1; miRNA-21-mimic could inhibit the expression of PDCD4, PTEN, and Spry1.
Figure 10. Subgroup analysis of arsenic exposure dose. SMD, standardized mean difference. miRNA-21, An endogenous non-coding RNA; STAT3, signal transducer and activator of transcription 3; pSTAT3, phosphorylated signal transduction and activator of transcription 3; PDCD4, programmed cell death protein 4; PTEN, phosphatase and tensin homolog; Spry1, protein sprouty homolog 1; E-cadherin, a type of cell adhesion molecule. Arsenic can promote the expression of miRNA-21 under low or high dose exposure. The inhibitory effect of low dose of arsenic on PDCD4 and Spry1 was more obvious. The inhibitory effect of high dose arsenic on pSTAT3 and E-cadherin is more obvious.
Figure 11. Subgroup analysis of arsenic exposure time. SMD, standardized mean difference. miRNA-21, An endogenous non-coding RNA; STAT3, signal transducer and activator of transcription 3; pSTAT3, phosphorylated signal transduction and activator of transcription 3; PDCD4, programmed cell death protein 4. Prolonged arsenic exposure could promote the expression of miRNA-21 and STAT3 and inhibit the expression of pSTAT3 and PDCD4.
Table 1. Characteristics of the Studies Included in the Meta-analysis
Authors Year Language n Arsenic Type Arsenic Dose (μmol/L) Exposure Duration (h) Outcome Indicators Country Lu Xiaolin et al.[12] 2015 English 3 NaAsO2 ≤ 5 ≤ 24 1, 2, 3, 7, 9 China Ling Min et al.[13] 2012 English 3 NaAsO2 ≤ 5 ≤ 24 1, 4, 5, 6 China Pratheeshkumar et al.[6] 2016 English 3 As2O3 > 5 > 24 1, 2, 3, 4, 7 America Gu Jingyi et al.[9] 2011 English 3 As2O3 ≤ 5 ≤ 24 1 China Luo Fei et al.[8] 2013 English 3 NaAsO2 ≤ 5 ≤ 24 1, 2, 3, 7, 8, 9 China Liu Xinlu et al.[4] 2016 English 3 NaAsO2 > 5 ≤ 24 1, 4, 5, 6 China Banerjee Nilanjana et al.[15] 2017 English 45 As2O3 ≤ 5 > 24 4, 5 India Xu Yuan et al.[16] 2015 English 3 NaAsO2 ≤ 5 ≤ 24 2, 3, 5 China Luo Fei et al.[17] 2015 English 3 NaAsO2 ≤ 5 ≤ 24 1, 4, 7, 8, 9 China Li Yumin et al.[18] 2010 English 3 As2O3 ≤ 5 ≤ 24 4 China Zhao Yue et al.[19] 2013 English 3 NaAsO2 ≤ 5 > 24 1 China Zhao Xin et al.[20] 2015 English 6 As2O3 ≤ 5 ≤ 24 1, 6 China Lu Shen et al.[21] 2013 English 3 NaAsO2 ≤ 5 ≤ 24 1, 6 China Cárdenas-González M et al.[10] 2016 English 27 As2O3 ≤ 5 > 24 1 Mexico Sun Jiaying et al.[7] 2014 English 3 As2O3 > 5 ≤ 24 1, 2, 3 China Chen Bailing et al.[22] 2013 English 3 As2O3 > 5 ≤ 24 1, 2, 3 China Li Yumin et al.[23] 2010 Chinese 3 As2O3 ≤ 5 ≤ 24 4 China He Qian et al.[34] 2013 English 3 As2O3 ≤ 5 > 24 1, 4, 5 China Lu Lu et al.[35] 2018 English 3 As2O3 > 5 > 24 1, 5 China Liu Haiwei et al.[36] 2018 English 3 As2O3 > 5 ≤ 24 1, 5 China Note. n, number within the experimental group; miRNA-21, an endogenous non-coding RNA; STAT3, signal transducer and activator of transcription 3; pSTAT3, phosphorylated signal transduction and activator of transcription 3; PDCD4, programmed cell death protein 4; PTEN, phosphatase and tensin homolog; Spry1, protein sprouty homolog 1; E-cadherin, a type of cell adhesion molecule; N-cadherin, a type of cell adhesion molecule; Vimentin, a type Ⅲ intermediate filament protein. 1, miRNA-21; 2, STAT3; 3, pSTAT3; 4, PDCD4; 5, PTEN; 6, Spry1; 7, E-cadherin; 8, N-cadherin; 9, Vimentin. Table 2. Comprehensive Dose-response Data from Five Articles on miRNA-21 at Different Doses of Arsenic
ID Author Year Dose [Mean ± SD) μmol/L] 0 2 5 10 15 20 1 Pratheeshkumar et al.[6] 2016 10.30 ± 0.01 13.56 ± 0.14 15.43 ± 0.04 13.54 ± 0.02 - - 2 Liu Xinlu et al.[4] 2016 10.02 ± 0.12 15.32 ± 0.14 11.73 ± 0.11 10.42 ± 0.13 9.23 ± 0.16 - 3 Gu J (K562) et al.[9] 2011 10.34 ± 1.23 13.56 ± 2.43 16.34 ± 2.43 15.87 ± 2.13 14.32 ± 1.90 13.42 ± 1.63 4 Gu J (K562) et al.[9] 2011 11.00 ± 7.13 11.50 ± 7.01 15.80 ± 6.93 13.31 ± 7.32 11.67 ± 7.32 - 5 Sun J et al.[7] 2014 10.60 ± 5.32 11.30 ± 5.14 12.43 ± 5.43 11.43 ± 6.92 - - Note. Comprehensive dose-response data from five articles on miRNA-21 at different doses of arsenic. Dose, the dose of arsenic. Mean, the average expression of miRNA-21 under arsenic. SD, standard deviation of miRNA-21 expression under arsenic. -
[1] Zhou Youyou, Wang Yanfu, Su Juan, et al. Integration of microRNAome, proteomics and metabolomics to analyze arsenic induced malignant cell transformation. Oncotarget, 2017; 53, 90879-96. http://cn.bing.com/academic/profile?id=0f2adf26b9fc0c0eb6fb06e435e62788&encoded=0&v=paper_preview&mkt=zh-cn [2] Brenda C Minatel, Adam P Sage, Christine Anderson, et al. Environmental arsenic exposure:From genetic susceptibility to pathogenesis. Environ Int, 2018; 112, 183-97. doi: 10.1016/j.envint.2017.12.017 [3] Katherine M Hunt, Ritesh K Srivastava, Craig A Elmets, et al. The mechanistic basis of arsenicosis:Pathogenesis of skin cancer. Cancer Lett, 2014; 354, 211-9. doi: 10.1016/j.canlet.2014.08.016 [4] Liu Xinlu, Luo Fei, Ling Min, et al. MicroRNA-21 activation of ERK signaling via PTEN is involved in arsenite-induced autophagy in human hepatic L-02 cells. Toxicol Lett, 2016; 252, 1-10. doi: 10.1016/j.toxlet.2016.04.015 [5] Tang Yiting, Zhou Xifa, Ji Jianfeng, et al. High expression levels of miR-21 and miR-210 predict unfavorable survival in breast cancer:a systemic review and meta-analysis. Int J Biol Marker, 2015; 30, e347-58. doi: 10.5301/jbm.5000160 [6] Poyil Pratheeshkumar, Young-Ok Son, Sasidharan Padmaja Divya, et al. Oncogenic transformation of human lung bronchial epithelial cells induced by arsenic involves ROS-dependent activation of STAT3-miR-21-PDCD4 mechanism. Sci Rep-uk, 2016; 6, 37227. doi: 10.1038/srep37227 [7] Sun Jiaying, Yu Miaomiao, Lu Yongju, et al. Carcinogenic metalloid arsenic induces expression of mdig oncogene through JNK and STAT3 activation. Cancer Lett, 2014; 346, 257-63. doi: 10.1016/j.canlet.2014.01.002 [8] Luo Fei, Xu Yuan, Ling Min, et al. Arsenite evokes IL-6 secretion, autocrine regulation of STAT3 signaling, and miR-21 expression, processes involved in the EMT and malignant transformation of human bronchial epithelial cells. Toxicol Appl Pharm, 2013; 273, 27-34. doi: 10.1016/j.taap.2013.08.025 [9] Gu Jingyi, Zhu Xuejiao, Li Yumin, et al. miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines. Med Oncol, 2011; 28, 211-8. doi: 10.1007/s12032-009-9413-7 [10] Cárdenas-González M, Osorio-Yáñez C, Gaspar-Ramírez O, et al. Environmental exposure to arsenic and chromium in children is associated with kidney injury molecule-1. Environ Res, 2016; 150, 653-62. doi: 10.1016/j.envres.2016.06.032 [11] Li Dongjie, Wei Yutao, Xu Shangzhi, et al. A systematic review and meta‑analysis of bidirectional effect of arsenic on ERK signaling pathway. Mol Med Rep, 2017; 17, 4422-32. http://cn.bing.com/academic/profile?id=45fe68234a44a0e11ad8a159747e4956&encoded=0&v=paper_preview&mkt=zh-cn [12] Lu Xiaolin, Luo Fei, Liu Yi, et al. The IL-6/STAT3 pathway via miR-21 is involved in the neoplastic and metastatic properties of arsenite-transformed human keratinocytes. Toxicol Lett, 2015; 237, 191-9. doi: 10.1016/j.toxlet.2015.06.011 [13] Ling Min, Li Yuan, Xu Yuan, et al. Regulation of miRNA-21 by reactive oxygen species-activated ERK/NF-κB in arsenite-induced cell transformation. Free Radical Bio Med, 2012; 52, 1508-18. doi: 10.1016/j.freeradbiomed.2012.02.020 [14] Wang Zhao-Xia, Lu Bin-Bin, Wang He, et al. MicroRNA-21 Modulates Chemosensitivity of Breast Cancer Cells to Doxorubicin by Targeting PTEN. Arch Med Res, 2011; 42, 281-90. doi: 10.1016/j.arcmed.2011.06.008 [15] Nilanjana Banerjee, Apurba K Bandyopadhyay, Suman Dutta, et al. Increased microRNA 21 expression contributes to arsenic induced skin lesions, skin cancers and respiratory distress in chronically exposed individuals. Toxicology, 2017; 378, 10-6. doi: 10.1016/j.tox.2017.01.006 [16] Xu Yuan, Luo Fei, Liu Yi, et al. Exosomal miR-21 derived from arsenite-transformed human bronchial epithelial cells promotes cell proliferation associated with arsenite carcinogenesis. Arch Toxicol, 2015; 89, 1071-82. doi: 10.1007/s00204-014-1291-x [17] Luo Fei, Ji Jie, Liu Yi, et al. MicroRNA-21, up-regulated by arsenite, directs the epithelial mesenchymal transition and enhances the invasive potential of transformed human bronchial epithelial cells by targeting PDCD4. Toxicol Lett, 2015; 232, 301-9. doi: 10.1016/j.toxlet.2014.11.001 [18] Li Yumin, Zhu Xuejiao, Gu Jingyi, et al. Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis. Cancer Res, 2010; 101, 948-54. http://cn.bing.com/academic/profile?id=0bdc4af2bd9894c983e46104f33315b9&encoded=0&v=paper_preview&mkt=zh-cn [19] Zhao Yue, Xu Yuan, Luo Fei, et al. Angiogenesis, mediated by miR-21, is involved arsenite-induced carcinogenesis. Toxicol Lett, 2013; 223, 35-41. doi: 10.1016/j.toxlet.2013.08.020 [20] Zhao Xin, Shi Yuan-Qi, Yan Cai-Chuan, et al. Up-regulation of miR-21 and miR-23a Contributes to As2O3-induced hERG Channel Deficiency. Basic Clin Pharmacol, 2015; 116, 516-23. doi: 10.1111/bcpt.2015.116.issue-6 [21] Shen Lu, Ling Min, Li Yuan, et al. Feedback regulations of miR-21 and MAPKs via Pdcd4 and Spry1 Are Involved in Arsenite-Induced Cell Malignant Transformation. Plos One, 2013; 8, e57652. doi: 10.1371/journal.pone.0057652 [22] Chen Bailing, Liu Jia, Chang Qingshan, et al. JNK and STAT3 signaling pathways converge on Akt-mediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic. Cell Cycle, 2013; 12, 112-21. doi: 10.4161/cc.23030 [23] Li Yuming, Gu Jingyi, Zhu Xuejiao, et al. Study on the sensitivity of leukemic cells to arsenic trioxide enhanced by targeted suppression of mIRNA21. Chin J Integr Trad West Med, 2010; 30, 170-3. (In Chinese) http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zxyjh201002016 [24] Wang Zhao-Xia, Lu Bin-Bin, Wang He, et al. MicroRNA-21 Modulates Chemosensitivity of Breast Cancer Cells to Doxorubicin by Targeting PTEN. Arch Med Res, 2011; 42, 281-90. doi: 10.1016/j.arcmed.2011.06.008 [25] Rebecca T Marquez, Erik Wendlandt, Courtney Searcey Galle, et al. MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-κB signaling. AM J Physiol-gastr L, 2010; 298, G535-41. http://d.old.wanfangdata.com.cn/OAPaper/oai_pubmedcentral.nih.gov_2853303 [26] Sha Min, Ye Jun, Zhang Li-xin, et al. Celastrol Induces Apoptosis of Gastric Cancer Cells by miR-21 Inhibiting PI3K/Akt-NF-κB Signaling Pathway. Pharmacology, 2014; 93, 39-46. doi: 10.1159/000357683 [27] Mao Xu-Hua, Chen Min, Wang Yan, et al. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4 and PTEN. Mol Carcinogen, 2016; 56, 886-910. http://www.ncbi.nlm.nih.gov/pubmed/27533779 [28] Radha Madhyastha, Harish Kumar Madhyastha, Yutthana Pengjam, et al. NFkappaB activation is essential for miR-21 induction by TGFb1 in high glucose conditions. Biochem bioph Res Co, 2014; 451, 615-21. doi: 10.1016/j.bbrc.2014.08.035 [29] Amit Bera, Nandini Ghosh-Choudhury, Nirmalya Dey, et al. NFκB-mediated cyclin D1 expression by microRNA-21 influences renal cancer cell proliferation. Cell Signal, 2013; 25, 2575-86. doi: 10.1016/j.cellsig.2013.08.005 [30] Ling Min, Li Yuan, Xu Yuan, et al. Regulation of miRNA-21 by reactive oxygen species-activated ERK/NF-κB in arsenite-induced cell transformation. Free Radical Bio med, 2012; 52, 1508-18. doi: 10.1016/j.freeradbiomed.2012.02.020 [31] Wei C, Li L, Kim IK, et al. NF-κB mediated miR-21 regulation in cardiomyocytes apoptosis under oxidative stress. Free Radical Res, 2014; 48, 282-91. doi: 10.3109/10715762.2013.865839 [32] Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions 5.2[updated June 2017]. In: The Cochrane Library, version 5.2. Chichester, UK: John Wiley & Sons, Ltd, 2017. [33] Xu Mengchuan, Rui Dongsheng, Yan Yizhong, et al. Oxidative Damage Induced by Arsenic in Mice or Rats:A Systematic Review and Meta-Analysis. Biol Trace Elem Res, 2017; 176, 154-75. doi: 10.1007/s12011-016-0810-4 [34] He Qian, Cai Lei, Shuai Ling, et al. Ars2 Is Overexpressed in Human Cholangiocarcinomas and Its Depletion Increases PTEN and PDCD4 by Decreasing MicroRNA-21. Molecular Carcinogenesis, 2013; 52, 286-96. doi: 10.1002/mc.v52.4 [35] Lu Lu, Xu Hui, Yang Ping, et al. Involvement of HIF-1α-regulated miR-21, acting via the Akt/NF-κB pathway, in malignant transformation of HBE cells induced by cigarette smoke extract. Toxicol Lett, 2018; 289. http://www.ncbi.nlm.nih.gov/pubmed/29501572 [36] Liu Haiwei, Cheng Le, Cao Dengke, et al. Suppression of miR-21 Expression Inhibits Cell Proliferation and Migration of Liver Cancer Cells by Targeting Phosphatase and Tension Homolog (PTEN). Med Sci Monitor, 2018; 24, 3571-7. doi: 10.12659/MSM.907038 [37] Alessio Crippa, Nicola Orsini. Dose-response meta-analysis of differences in means. BMC Med Res Methodol, 2016; 16, 91. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971698/ -
下载: